The Department of Health and Social Care (DH) has issued supply notification for various strengths of three H2-antagonists- Cimetidine, Famotidine, and Nizatidine.

Product Supplier Anticipated Resupply date Detail
Famotidine 20mg tablets Tilomed Laboratories Out of stock, resupply mid October 2020
Teva UK Out of stock, resupply w/c 5th October 2020
Famotidine 40mg tablets Tilomed Laboratories In stock
Teva UK Out of stock, resupply w/c 5th October 2020
Cimetidine 200mg tablets Ennogen Pharma June 2021 Unlicensed supplies have been sourced
Medreich to be confirmed
Cimetidine 400mg tablets Ennogen Pharma June 2021
Medreich to be confirmed
Cimetidine 800mg tablets Ennogen Pharma June 2021
Medreich to be confirmed
Cimetidine 200mg/5ml oral solution Rosemont Pharmaceuticals n/a In stock
Nizatidine 150mg tablets Mylan Out of stock, resupply December 2020
Medreich to be confirmed
Relonchem In stock
Nizatidine 300mg tablets  Mylan Out of stock, resupply December 2020
Medreich to be confirmed
Relonchem In stock

 

The following specialist importers have confirmed that they can source unlicensed Cimetidine tablets.

  • Alium Medical (200mg, 400mg and 800mg)
  • Mawdsley’s Unlicensed (400mg)

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Cimetidine (strength) tablets cannot be issued.

If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY